Masdiag Supports Launch of Mongolia's National Newborn Screening Programme

A Milestone for Public Health in Mongolia

The National Center for Maternal and Child Health in Ulaanbaatar has taken its first major steps toward implementing a nationwide newborn screening (NBS) programme — a landmark moment for public health in the region.

For Masdiag, being able to contribute to this initiative represents the culmination of many years dedicated to advancing diagnostic methods for inborn errors of metabolism and rare diseases.

The Partnership

The initiative is led by Esun Med LLC in partnership with UNICEF Mongolia, with Masdiag providing analytical expertise and method transfer support. The programme aims to establish systematic newborn screening capabilities for the detection of inherited metabolic disorders at a national scale.

Masdiag's role centres on the transfer of validated LC-MS/MS methods for dried blood spot analysis — the same platform that underpins our commercial screening services across Europe.

Why Newborn Screening Matters

Many inherited metabolic disorders are treatable when detected early, but devastating when diagnosis is delayed. Newborn screening programmes represent one of the most cost-effective public health interventions available, with the potential to prevent irreversible neurological damage, organ failure, and premature death.

For Mongolia, this programme opens the door to early detection of conditions that were previously identified only after clinical symptoms — often too late for effective intervention.

Acknowledgements

Masdiag extends sincere thanks to the entire laboratory team led by Dr. Jamiyan at the National Center for Maternal and Child Health in Ulaanbaatar, as well as colleagues at SCIEX for their collaboration and support throughout this project.